SAN DIEGO, April 26, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ:DNAY), a pioneer in automated benchtop synthetic biology systems, today announced the completion of proof-of-concept demonstrations showing that its technology can be used effectively for encoding digital data in DNA sequences, and that the information that was stored could be retrieved accurately afterward. This validation is an important step in the company’s efforts to develop next-generation tools and applications for DNA data storage.
Codex DNA Demonstrates End-to-End Workflow for Storing and Retrieving Data in Synthetic DNA
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/Technology%20abstract%20by%20TU%20IS%20via%20iStock.jpg)
/Micron%20Technology%20Inc_%20logo%20on%20building-by%20vzphotos%20vis%20iStock.jpg)
